Three-Month FVC Change: A Trial Endpoint for Idiopathic Pulmonary Fibrosis Based on Individual Participant Data Meta-analysis

File(s)

rccm.202109-2091oc_khan.pdf (827.09 KB)

Published version

Show more

Author(s)

Khan, FA

Stewart, I

Moss, S

Fabbri, L

Robinson, KA

more

Type

Journal Article

Date Issued

2022-04-15

URI

http://hdl.handle.net/10044/1/98192

DOI

10.1164/rccm.202109-2091OC

ISSN

1073-449X

Publisher

AMER THORACIC SOC

Start Page

936

End Page

948

Journal / Book Title

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Volume

205

Issue

8

Copyright Statement

© 2022 by the American Thoracic Society
Originally Published in Press as DOI: 10.1164/rccm.202109-2091OC on January 12, 2022
Internet address: www:atsjournals:org

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000783695900015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Subjects

Science & Technology

Life Sciences & Biomedicine

Critical Care Medicine

Respiratory System

General & Internal Medicine

spirometry

gas transfer for carbon monoxide

6-minute-walk test

mortality

interstitial lung disease

MORTALITY

PIRFENIDONE

EFFICACY

BOSENTAN

BIAS

6-minute-walk test

gas transfer for carbon monoxide

interstitial lung disease

mortality

spirometry

Disease Progression

Humans

Idiopathic Pulmonary Fibrosis

Proportional Hazards Models

Vital Capacity

Humans

Disease Progression

Vital Capacity

Proportional Hazards Models

Idiopathic Pulmonary Fibrosis

Respiratory System

11 Medical and Health Sciences

Publication Status

Published